Download PDF
Aktuelle Dermatologie 2011; 37(6): 199-204
DOI: 10.1055/s-0030-1256328
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Diagnostik primär kutaner B-Zell-Lymphome

Diagnostic Criteria of Primary Cutaneous B-Cell LymphomasM.  Felcht1 , C.-D.  Klemke1
  • 1Klinik für Dermatologie, Venerologie and Allergologie, Universitätsklinikum Mannheim, Ruprecht-Karls-Universität Heidelberg
Further Information

Publication History

Publication Date:
18 April 2011 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Primär kutane B-Zell-Lymphome (PCBCL) sind seltene Erkankungen der Haut. Die drei wichtigsten Subtypen sind die indolent verlaufenden primär kutanen follikulären Lymphome (PCFCL) und die primär kutanen Marginalzonenlymphome (PCMZL) sowie das deutlich aggressiver verlaufende primär kutane diffus großzellige B-Zell-Lymphom des Beines (PCLBCL, LT). Bei der Verdachtsdiagnose PCBCL muss zunächst ein nodales Lymphom mit sekundärer Hautbeteiligung durch entsprechende Staginguntersuchungen ausgeschlossen werden. Die Differenzierung zwischen den einzelnen Subtypen ist in den meisten Fällen mittels Anamnese, Klinik und (Immun)-Histologie möglich. In Einzelfällen erscheinen molekular-biologische Untersuchungen gerechtfertigt.

Abstract

Primary cutaneous B-cell lymphomas (PCBL) are rare skin tumors. The three major subtypes are the indolent variants primary cutaneous follicle centre lymphoma (PCFCL) and primary cutaneous marginal zone lymphoma (PCMZL), and the more aggressive PCBCL primary cutaneous diffuse large B-cell lymphoma, leg type (PCLBCL, LT). After a nodal lymphoma with secondary skin involvement has been excluded by staging procedures, the differentiation between the subtypes is in most cases possible by the medical history, clinical examination and (immuno)-histochemical analysis. However, in some cases molecular analyses are required to achieve diagnosis.

█Schlüsselwörter

Primär kutane B-Zell-Lymphome - PCFCL - PCMZL - PCLBCL - LT

█Key words

primary cutaneous B-cell lymphoma - PCFCL - PCMZL - PCLBCL - LT

Literatur

  • 1 Turner J J, Morton L M, Linet M S et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions.  Blood. 2010;  116 (20) in press
    PubMedGoogle Scholar
  • 2 Groves F D, Linet M S, Travis L B, Devesa S S. Cancer surveillance series: non-Hodgkin’s lymphoma incidence by histologic subtype in the United States from 1978 through 1995.  J Natl Cancer Inst. 1995;  92 (15) 1240-1251
    PubMedGoogle Scholar
  • 3 Bradford P T, Devesa S S, Anderson W F, Toro J R. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.  Blood. 2009;  113 (21) 5064-5073
    CrossrefPubMedGoogle Scholar
  • 4 Jenni D, Karpova M B, Seifert B et al. Primary cutaneous lymphoma: Two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre.  Br J Dermatol. 2010 Nov 16;  [Epub ahead of print]
    PubMedGoogle Scholar
  • 5 Willemze R, Jaffe E S, Burg G et al. WHO-EORTC classification of cutaneous lymphomas.  Blood. 2005;  105 3768-3785
    CrossrefPubMedGoogle Scholar
  • 6 Senff N J, Noordijk E M, Kim Y H et al. European Organization for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphoma (ISCL) consensus recommandations for the management of cutaneous B-cell lymphomas.  Blood. 2008;  112 (5) 1600-1609
    CrossrefPubMedGoogle Scholar
  • 7 Stadler R, Assaf C, Klemke C-D et al. Short German guidelines: Cutaneous lymphomas.  J Deut Dermatol Ges. 2008;  6 S25-S31
    PubMedGoogle Scholar
  • 8 Ponzoni M, Ferreri A JM, Campo E et al. Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting.  J Clin Oncol. 2007;  25 (21) 3168-3173
    CrossrefPubMedGoogle Scholar
  • 9 Kim F Y, Willemze R, Pimpinelli N et al. TNM classification system for primary cutaneous lymphomas others than mycosis fungoides and Sézary Syndrom: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treamtent of Cancer (EORTC).  Blood. 2007;  110 479-484
    CrossrefPubMedGoogle Scholar
  • 10 Senff N J, Hoefnagel J, Neelis K et al. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.  Arch Dermatol. 2007;  143 (12) 1520-1526
    CrossrefPubMedGoogle Scholar
  • 11 Senff N J, Hoefnagel J J, Jansen P M et al. Reclassification of 300 Primary Cutaneous B-Cell Lymphomas According to the New WHO-EORTC Classification for Cutaneous Lymphomas: Complarison With Previous Classifications and Identification of Prognostic Markers.  J Clin Oncol. 2007;  25 1581-1587
    CrossrefPubMedGoogle Scholar
  • 12 Senff N J, Willemze R. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used in the Dutch Cutaneous Lymphoma Group.  Br J Dermatol. 2007;  157 (6) 1205-1211
    CrossrefPubMedGoogle Scholar
  • 13 Gerami P, Wickless S C, Rosen S et al. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.  J Am Acad Dermatol. 2008;  59 (2) 245-254
    CrossrefPubMedGoogle Scholar
  • 14 Zinzani P L, Quaglino P, Pimpinelli N et al. Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous Lymphomas.  J Clin Oncol. 2006;  24 (9) 1376-1382
    CrossrefPubMedGoogle Scholar
  • 15 Assaf C, Gellrich S, Steinhoff M et al. Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG).  J Deut Dermatol Ges. 2007;  5 662-669
    PubMedGoogle Scholar
  • 16 Willemze R. Primary cutaneous B-cell lymphoma: classification and treatment.  Curr Opin Oncol. 2006;  18 425-431
    CrossrefPubMedGoogle Scholar
  • 17 Senff N J, Kluin-Nelemans H C, Willemze R. Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphomas.  Br J Haematol. 2008;  142 52-56
    CrossrefPubMedGoogle Scholar
  • 18 Hoefnagel J J, Vemeer M H, Jansen P et al. Primary Cutaneous Marginal Zone B-Cell Lymphoma.  Arch Dermatol. 2005;  141 1139-1145
    CrossrefPubMedGoogle Scholar
  • 19 Garbea A, Dippel E, Hildenbrand R et al. Cutaneous large B-cell lymphoma of the leg masquerading as a chronic venous ulcer.  Br J Dermatol. 2002;  146 144-147
    CrossrefPubMedGoogle Scholar
  • 20 Nakayama S, Yokote T, Kobayashi K et al. Primary cutaneous diffuse large B-cell lymphoma, leg type, with features simulating POEMS syndrome.  Eur J Haematol. 2010;  84 (1) 79-83
    CrossrefPubMedGoogle Scholar
  • 21 Burg G, Kempf W, Cozzio A et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.  J Cutan Pathol. 2005;  32 647-674
    CrossrefPubMedGoogle Scholar
  • 22 Cerroni L, Volkenandt M, Rieger E et al. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas.  The Journal of investigative dermatology. 1994;  102 (2) 231-235
    CrossrefPubMedGoogle Scholar
  • 23 Hoefnagel J J, Vermeer M H, Jansen P M et al. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.  Br J Dermatol. 2003;  149 1183-1191
    CrossrefPubMedGoogle Scholar
  • 24 Kodama K, Massone C, Chott A et al. Primary cutaneous large B-cell lymphomas: clinicopathological features, classification, and prognostic factors in a large series of patients.  Blood. 2005;  106 2491-2497
    CrossrefPubMedGoogle Scholar
  • 25 Hoefnagel J J, Dijkman R, Basso K et al. Dinstinct types of primary cutaneous large B-cell lymphoma identified by gene expressing profiling.  Blood. 2005;  105 3671-3678
    CrossrefPubMedGoogle Scholar
  • 26 Paulli M, Viglio A, Vivenza D et al. Primary Cutaneous Large B-Cell Lymphoma of the Leg: Histogenetic Analysis of a Controversial Clinicopathologic Entity.  Hum Path. 2002;  33 (9) 937-943
    CrossrefPubMedGoogle Scholar
  • 27 Sandberg Y, van Gastel-Mol E J, Verhaaf B et al. BIOMED-2 multiplex immunoglobulin/T-cell receptor polymerase chain reaction protocols can reliably replace southern blot analysis in routine clonality diagnostics.  J Mol Diagn. 2005;  7 495-503
    CrossrefPubMedGoogle Scholar
  • 28 Klemke C D, Dippel E, Dembinski A et al. Clonal T cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in the skin and blood of patients with parapsoriasis and early-stage mycosis fungoides.  J Pathol. 2002;  197 (3) 348-354
    CrossrefPubMedGoogle Scholar
  • 29 McClure R F, Kaur P, Pagel E et al. Validation of immunoglobulin gene rearrangements detection by PCR using commerically available BIOMED-2 primer.  Leukemia. 2006;  20 176-179
    CrossrefPubMedGoogle Scholar
  • 30 Klemke C D, Fritzsching B, Franz B et al. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas.  Leukemia. 2006;  20 (6) 1123-1129
    CrossrefPubMedGoogle Scholar
  • 31 Evans P, Pott C, Groenen P et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936.  Leukemia. 2007;  21 207-214
    CrossrefPubMedGoogle Scholar
  • 32 Morales A V, Arber D A, Seo K et al. Evaluation of B-Cell Clonality Using the BIOMED-2 PCR Method Effectively Distinguishes Cutaneous B-Cell Lymphoma From Beningn Lymphoid Malignancies.  Am J Dermatopathol. 2008;  30 425-430
    CrossrefPubMedGoogle Scholar
  • 33 Felcht M, Booken N, Stroebel P et al. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinic, histology and immunohistochemistry.  J Am Acad Dermatol. 2011;  64 (1) 135-143
    CrossrefPubMedGoogle Scholar
  • 34 Dippel E, Assaf C, Hummel M et al. Clonal T-Cell receptor gamma-chain gene rearrangment by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation.  J Pathol. 1999;  188 (2) 146-154
    CrossrefPubMedGoogle Scholar
  • 35 Dippel E, Klemke C-D, Hummel M et al. T-cell clonality of undetermined significance.  Blood. 2001;  98 (1) 247-248
    CrossrefPubMedGoogle Scholar
  • 36 Klemke C-D, Poenitz N, Dippel E et al. T-Cell Clonality of Undetermined Significance.  Arch Dermatol. 2006;  142 393-394
    PubMedGoogle Scholar

PD Dr. med. Claus-Detlev Klemke MD 

Klinik für Dermatologie, Venerologie und Allergologie
Universitätsklinikum Mannheim
Ruprecht-Karls-Universität Heidelberg

Theodor-Kutzer-Ufer 1 – 3
68135 Mannheim

Email: Claus-Detlev.Klemke@umm.de